Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian J Miles, MD, FACS
Baylor College of Medicine and Methodist Hospital
Principal Investigator - Christopher J Kane, MD
University of California, San Diego
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsd Moores Cancer Center
San Diego, California, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- the Methodist Hospital Research Institute
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2013
- Primary completion
- 6 Jul 2018
- Completion
- 31 Mar 2020
- Last update posted
- 4 Sept 2020
- Registered enrollment
- 28
- Registry id
- NCT01931046
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.